EWM
GILD icon

Empirical Wealth Management’s Gilead Sciences GILD Stock Holding History

Empirical Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.6M Sell
84,179
-1,790
-2% -$236K 0.16% 104
2026
Q1 		$12M Buy
85,969
+1,485
+2% +$208K 0.21% 86
2025
Q4 		$10.4M Buy
84,484
+5,990
+8% +$728K 0.18% 95
2025
Q3 		$8.71M Buy
78,494
+26,882
+52% +$3.06M 0.17% 101
2025
Q2 		$5.72M Sell
51,612
-9,506
-16% -$1.01M 0.13% 120
2025
Q1 		$6.85M Sell
61,118
-81,049
-57% -$8.36M 0.18% 104
2024
Q4 		$13.1M Buy
142,167
+5,382
+4% +$485K 0.36% 57
2024
Q3 		$11.5M Buy
136,785
+32,963
+32% +$2.52M 0.32% 65
2024
Q2 		$7.12M Sell
103,822
-11,018
-10% -$735K 0.21% 90
2024
Q1 		$8.41M Buy
114,840
+15,304
+15% +$1.18M 0.25% 79
2023
Q4 		$8.06M Buy
99,536
+6,980
+8% +$543K 0.27% 76
2023
Q3 		$6.94M Buy
92,556
+11,577
+14% +$890K 0.27% 76
2023
Q2 		$6.24M Buy
80,979
+67,177
+487% +$5.36M 0.25% 83
2023
Q1 		$1.15M Buy
13,802
+1,954
+16% +$162K 0.05% 196
2022
Q4 		$1.02M Buy
11,848
+6,232
+111% +$494K 0.05% 207
2022
Q3 		$346K Buy
5,616
+481
+9% +$30.3K 0.02% 350
2022
Q2 		$317K Sell
5,135
-3,507
-41% -$217K 0.02% 374
2022
Q1 		$514K Buy
8,642
+2,654
+44% +$170K 0.03% 326
2021
Q4 		$435K Buy
5,988
+1,522
+34% +$105K 0.02% 366
2021
Q3 		$312K Sell
4,466
-5,747
-56% -$404K 0.02% 373
2021
Q2 		$703K Buy
10,213
+467
+5% +$31.2K 0.04% 234
2021
Q1 		$630K Buy
9,746
+1
+0% +$64 0.05% 218
2020
Q4 		$568K Sell
9,745
-258
-3% -$15.6K 0.04% 232
2020
Q3 		$632K Buy
10,003
+194
+2% +$13.5K 0.05% 179
2020
Q2 		$755K Buy
9,809
+6,204
+172% +$475K 0.07% 159
2020
Q1 		$270K Buy
3,605
+144
+4% +$9.95K 0.03% 260
2019
Q4 		$225K Sell
3,461
-1,694
-33% -$110K 0.02% 295
2019
Q3 		$327K Sell
5,155
-799
-13% -$52.2K 0.04% 221
2019
Q2 		$402K Sell
5,954
-351
-6% -$23.1K 0.05% 176
2019
Q1 		$410K Buy
6,305
+836
+15% +$55.6K 0.06% 152
2018
Q4 		$342K Buy
5,469
+821
+18% +$57.4K 0.06% 150
2018
Q3 		$359K Sell
4,648
-150
-3% -$11.3K 0.06% 150
2018
Q2 		$340K Sell
4,798
-14
-0.3% -$989 0.06% 137
2018
Q1 		$363K Buy
4,812
+564
+13% +$44.8K 0.07% 116
2017
Q4 		$304K Hold
4,248
– – 0.07% 114
2017
Q3 		$344K Hold
4,248
– – 0.08% 101
2017
Q2 		$301K Hold
4,248
– – 0.07% 106
2017
Q1 		$289K Sell
4,248
-100
-2% -$7.03K 0.07% 102
2016
Q4 		$311K Sell
4,348
-63
-1% -$4.68K 0.08% 98
2016
Q3 		$349K Sell
4,411
-32
-0.7% -$2.6K 0.09% 83
2016
Q2 		$371K Sell
4,443
-168
-4% -$14.9K 0.1% 79
2016
Q1 		$424K Buy
4,611
+800
+21% +$72.1K 0.1% 74
2015
Q4 		$386K Buy
3,811
+918
+32% +$95.5K 0.09% 79
2015
Q3 		$284K Buy
2,893
+145
+5% +$16.1K 0.07% 97
2015
Q2 		$322K Hold
2,748
– – 0.07% 96
2015
Q1 		$270K Hold
2,748
– – 0.06% 87
2014
Q4 		$259K Hold
2,748
– – 0.06% 88
2014
Q3 		$293K Hold
2,748
– – 0.07% 82
2014
Q2 		$228K Buy
+2,748
New +$214K 0.06% 94
2014
Q1 		– Sell
-2,748
Closed -$206K – 100
2013
Q4 		$206K Buy
+2,748
New +$191K 0.06% 88

Other funds holding GILD

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Empirical Wealth Management's GILD Position: Q2 2026 in Review

Empirical Wealth Management reduced its Gilead Sciences (GILD) stake by 2.1% in Q2 2026, selling an estimated $236K and leaving 84,179 shares worth $10.6M. The position accounts for 0.16% of the portfolio, ranked #104.

Empirical Wealth Management first reported a position in GILD in Q4 2013 and has held it in 50 quarters since. The position peaked at $13.1M in Q4 2024. 895 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Empirical Wealth Management held 84,179 shares of Gilead Sciences worth $10.6M as of Q2 2026.
  • Empirical Wealth Management sold 1,790 Gilead Sciences shares in Q2 2026, an estimated $236K.
  • Gilead Sciences made up 0.16% of Empirical Wealth Management's portfolio in Q2 2026, its #104 holding.
  • Empirical Wealth Management first reported a position in Gilead Sciences in Q4 2013 and has held it in 50 quarters since.
  • Empirical Wealth Management's Gilead Sciences position peaked at $13.1M in Q4 2024.
  • 895 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Empirical Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.